The global endoscopic vessel harvesting systems market is entering a promising growth phase, anticipated to expand steadily from USD 577.1 million in 2025 to USD 949.0 million by 2035, registering a compound annual growth rate (CAGR) of 5.1%. This steady climb reflects the growing adoption of minimally invasive surgical procedures and the rising global prevalence of cardiovascular diseases.

Endoscopic vessel harvesting (EVH) systems have revolutionized surgical methods, especially in coronary artery bypass grafting (CABG) procedures. These systems enable the extraction of blood vessels with minimal trauma, improving patient recovery times, reducing complications, and enhancing surgical outcomes. In 2024, the global revenue from EVH systems stood at USD 552.2 million, laying a solid foundation for sustained growth throughout the next decade.

Fueling this momentum is a significant increase in ischemic heart disease cases worldwide. The demand for coronary artery bypass graft surgeries, a common procedure used to treat these conditions, continues to rise. EVH systems, which are primarily used for harvesting the saphenous vein and radial artery, have become essential tools for cardiac surgeons due to their ability to reduce incision sizes, blood loss, and postoperative pain.

Incorporating cutting-edge advancements in imaging technology, electrocautery tools, and robot-assisted surgical systems, EVH is transitioning into a more precise, ergonomic, and patient-centric procedure. However, the industry still faces challenges such as high system costs, training requirements, and regulatory complexities—factors that companies are working aggressively to overcome.

The U.S. EVH systems market is witnessing steady growth, driven by the increasing burden of cardiovascular diseases and a strong preference for minimally invasive surgeries. With a CAGR of 2.1% from 2025 to 2035, the country’s healthcare providers continue to adopt EVH systems to improve patient outcomes and surgical efficiencies. The robust healthcare infrastructure and emphasis on precision care further support market expansion.

Germany remains a key player in the European EVH market, backed by an advanced healthcare system and a strong commitment to quality patient care. With a projected CAGR of 3.8%, the country is embracing EVH systems as part of its broader push for surgical innovation and improved patient safety.

India represents a high-potential emerging market, with growth spurred by the rising prevalence of heart diseases and increasing investments in healthcare infrastructure. Urban medical centers are progressively adopting minimally invasive techniques, positioning India’s EVH market for a CAGR of 3.9% over the next decade.

Japan boasts a highly developed EVH landscape, owing to its sophisticated medical technologies and a healthcare system favoring minimally invasive interventions. The nation’s aging population, combined with its high surgical standards, is expected to drive a CAGR of 4.6%, one of the highest among major economies.

Brazil’s EVH market is growing in tandem with rising awareness and healthcare improvements. The surge in cardiovascular cases has prompted a move toward effective, less invasive surgical solutions, pushing the market toward a 3.5% CAGR.

The EVH systems market is becoming increasingly competitive, with global medical technology giants and emerging innovators vying for market share. The surge in cardiovascular cases, coupled with consumer demand for shorter recovery periods and fewer surgical complications, is propelling this competition. Players are investing heavily in automation, precision engineering, and user-friendly ergonomics to gain a technological edge.

Manufacturers are also aligning their strategies with the growing emphasis on robotic surgery integration, particularly in high-income markets. With the ongoing shift toward outpatient cardiac procedures, companies that can deliver compact, efficient, and intuitive EVH systems are expected to thrive.

These companies continue to innovate, focusing on expanding their product offerings to meet the evolving demands of cardiovascular surgeons and healthcare providers globally.

While developed regions are focusing on advanced integration and robotic-assisted EVH, emerging markets present enormous opportunities for market penetration and localized product development. However, companies must navigate challenges such as:

These barriers, if addressed through strategic partnerships, government collaborations, and focused R&D, could unlock significant value in untapped markets.

As EVH systems continue to redefine cardiac surgical standards, the global market stands at the cusp of a transformation. With innovations accelerating and awareness increasing, EVH systems are expected to become integral to modern cardiovascular treatment protocols. The next decade offers a lucrative and dynamic growth environment for players committed to innovation, precision, and better patient outcomes.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube